Previous Article | Next Article 
Molecular and Cellular Biology, April 2002, p. 2304-2317, Vol. 22, No. 7
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.7.2304-2317.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin
Janiel M. Shields,* Heena Mehta, Kevin Pruitt, and Channing J. Der*
Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Received 2 November 2001/
Returned for modification 10 December 2001/
Accepted 20 December 2001
We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Raf. One gene identified in these analyses encodes for
-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of ras, but high in transformation-impaired, derivative cell lines in which the mutant ras allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.
* Corresponding author. Mailing address: University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, CB 7295, Chapel Hill, NC 27599-7295. Phone: (919) 962-1057. Fax: (919) 966-0162. E-mail for Janiel M. Shields:
shieldsj{at}med.unc.edu. E-mail for Channing J. Der:
cjder{at}med.unc.edu.
Molecular and Cellular Biology, April 2002, p. 2304-2317, Vol. 22, No. 7
0022-538X/02/$04.00+0 DOI: 10.1128/MCB.22.7.2304-2317.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sebastian, T., Johnson, P. F.
(2009). RasV12-Mediated Down-regulation of CCAAT/Enhancer Binding Protein {beta} in Immortalized Fibroblasts Requires Loss of p19Arf and Facilitates Bypass of Oncogene-Induced Senescence. Cancer Res.
69: 2588-2598
[Abstract]
[Full Text]
-
Cheng, X.
(2008). Silent Assassin: Oncogenic Ras Directs Epigenetic Inactivation of Target Genes. Sci Signal
1: pe14-pe14
[Abstract]
[Full Text]
-
Gunning, P., O'neill, G., Hardeman, E.
(2008). Tropomyosin-Based Regulation of the Actin Cytoskeleton in Time and Space. Physiol. Rev.
88: 1-35
[Abstract]
[Full Text]
-
Shields, J. M., Thomas, N. E., Cregger, M., Berger, A. J., Leslie, M., Torrice, C., Hao, H., Penland, S., Arbiser, J., Scott, G., Zhou, T., Bar-Eli, M., Bear, J. E., Der, C. J., Kaufmann, W. K., Rimm, D. L., Sharpless, N. E.
(2007). Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma. Cancer Res.
67: 1502-1512
[Abstract]
[Full Text]
-
Meyer-ter-Vehn, T., Gebhardt, S., Sebald, W., Buttmann, M., Grehn, F., Schlunck, G., Knaus, P.
(2006). p38 Inhibitors Prevent TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts.. IOVS
47: 1500-1509
[Abstract]
[Full Text]
-
Lee, H.-Y., Oh, S.-H., Suh, Y.-A., Baek, J. H., Papadimitrakopoulou, V., Huang, S., Hong, W. K.
(2005). Response of Non-Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer. Clin. Cancer Res.
11: 6065-6074
[Abstract]
[Full Text]
-
Pruitt, K., Ulku, A. S., Frantz, K., Rojas, R. J., Muniz-Medina, V. M., Rangnekar, V. M., Der, C. J., Shields, J. M.
(2005). Ras-mediated Loss of the Pro-apoptotic Response Protein Par-4 Is Mediated by DNA Hypermethylation through Raf-independent and Raf-dependent Signaling Cascades in Epithelial Cells. J. Biol. Chem.
280: 23363-23370
[Abstract]
[Full Text]
-
Yuste, L., Esparis-Ogando, A., Santos, E., Pandiella, A.
(2005). Overexpression of RasN17 Fails to Neutralize Endogenous Ras in MCF7 Breast Cancer Cells. J Biochem
137: 731-739
[Abstract]
[Full Text]
-
Ruiz, C., Huang, W., Hegi, M. E., Lange, K., Hamou, M.-F., Fluri, E., Oakeley, E. J., Chiquet-Ehrismann, R., Orend, G.
(2004). Differential Gene Expression Analysis Reveals Activation of Growth Promoting Signaling Pathways by Tenascin-C. Cancer Res.
64: 7377-7385
[Abstract]
[Full Text]
-
Bakin, A. V., Safina, A., Rinehart, C., Daroqui, C., Darbary, H., Helfman, D. M.
(2004). A Critical Role of Tropomyosins in TGF-{beta} Regulation of the Actin Cytoskeleton and Cell Motility in Epithelial Cells. Mol. Biol. Cell
15: 4682-4694
[Abstract]
[Full Text]
-
Bharadwaj, S., Hitchcock-DeGregori, S., Thorburn, A., Prasad, G. L.
(2004). N Terminus Is Essential for Tropomyosin Functions: N-TERMINAL MODIFICATION DISRUPTS STRESS FIBER ORGANIZATION AND ABOLISHES ANTI-ONCOGENIC EFFECTS OF TROPOMYOSIN-1. J. Biol. Chem.
279: 14039-14048
[Abstract]
[Full Text]
-
Akimov, S. S., Belkin, A. M.
(2003). Opposing Roles of Ras/Raf Oncogenes and the MEK1/ERK Signaling Module in Regulation of Expression and Adhesive Function of Surface Transglutaminase. J. Biol. Chem.
278: 35609-35619
[Abstract]
[Full Text]
-
Lee, H.-Y., Srinivas, H., Xia, D., Lu, Y., Superty, R., LaPushin, R., Gomez-Manzano, C., Gal, A. M., Walsh, G. L., Force, T., Ueki, K., Mills, G. B., Kurie, J. M.
(2003). Evidence That Phosphatidylinositol 3-Kinase- and Mitogen-activated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell Survival. J. Biol. Chem.
278: 23630-23638
[Abstract]
[Full Text]
-
Janssen, R. A. J., Kim, P. N., Mier, J. W., Morrison, D. K.
(2003). Overexpression of Kinase Suppressor of Ras Upregulates the High-Molecular-Weight Tropomyosin Isoforms in ras-Transformed NIH 3T3 Fibroblasts. Mol. Cell. Biol.
23: 1786-1797
[Abstract]
[Full Text]
-
Pruitt, K., Pruitt, W. M., Bilter, G. K., Westwick, J. K., Der, C. J.
(2002). Raf-independent Deregulation of p38 and JNK Mitogen-activated Protein Kinases Are Critical for Ras Transformation. J. Biol. Chem.
277: 31808-31817
[Abstract]
[Full Text]